Pathogenesis of Olfactory Disorders in COVID-19

Overview

Journal Brain Sci

Publisher MDPI

Date 2022 Apr 21

PMID 35447981

Authors

Laura Ziuzia-Januszewska

Marcin Januszewski

Affiliations

Soon will be listed here.

Abstract

Since the outbreak of the SARS-CoV-2 pandemic, olfactory disorders have been reported as a frequent symptom of COVID-19; however, its pathogenesis is still debated. The aim of this review is to summarize the current understanding of the pathogenesis of smell impairment in the course of COVID-19 and to highlight potential avenues for future research on this issue. Several theories have been proposed to explain the pathogenesis of COVID-19-related anosmia, including nasal obstruction and rhinorrhea, oedema of the olfactory cleft mucosa, olfactory epithelial damage either within the olfactory receptor cells or the supporting non-neural cells (either direct or immune-mediated), damage to the olfactory bulb, and impairment of the central olfactory pathways. Although the pathogenesis of COVID-19-related anosmia is still not fully elucidated, it appears to be mainly due to sensorineural damage, with infection of the olfactory epithelium support cells via the ACE1 receptor and disruption of the OE caused by immense inflammatory reaction, and possibly with direct olfactory sensory neurons infection mediated by the NRP-1 receptor. Involvement of the higher olfactory pathways and a conductive component of olfactory disorders, as well as genetic factors, may also be considered.

Citing Articles

Inflammatory Response and Defects on Myelin Integrity in the Olfactory System of K18hACE2 Mice Infected with SARS-CoV-2.

Martin-Lopez E, Brennan B, Mao T, Spence N, Meller S, Han K eNeuro. 2024; 11(6).

PMID: 38834299 PMC: 11185043. DOI: 10.1523/ENEURO.0106-24.2024.

Assessment of smell disturbances 6 months after COVID-19 in Polish population.

Okrzeja J, Solomacha S, Alimowski M, Sowa P, Dubatowka M, Lapinska M Sci Rep. 2024; 14(1):11251.

PMID: 38755270 PMC: 11099038. DOI: 10.1038/s41598-024-62114-y.

DellAquila M, Cafiero C, Micera A, Stigliano E, Ottaiano M, Benincasa G Biomedicines. 2024; 12(4).

PMID: 38672185 PMC: 11048640. DOI: 10.3390/biomedicines12040830.

Prevalence and association of oral manifestations with disease severity in patients diagnosed with COVID‑19: A cross‑sectional study.

Campeanu A, Rus M, Ispas S, Herlo A, Craciun A, Ionescu C Med Int (Lond). 2024; 4(3):30.

PMID: 38660127 PMC: 11040283. DOI: 10.3892/mi.2024.154.

Corticosteroids for COVID-19-induced olfactory dysfunction: A comprehensive systematic review and meta-analysis of randomized controlled trials.

Wang J, Pao J, Lee C, Wang J, Lee M, Wu T PLoS One. 2023; 18(12):e0289172.

PMID: 38127940 PMC: 10734960. DOI: 10.1371/journal.pone.0289172.

References

Spinato G, Fabbris C, Polesel J, Cazzador D, Borsetto D, Hopkins C . Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection. JAMA. 2020; 323(20):2089-2090. PMC: 7177631. DOI: 10.1001/jama.2020.6771. View

Zazhytska M, Kodra A, Hoagland D, Frere J, Fullard J, Shayya H . Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell. 2022; 185(6):1052-1064.e12. PMC: 8808699. DOI: 10.1016/j.cell.2022.01.024. View

Ueha R, Kondo K, Kagoya R, Shichino S, Yamasoba T . ACE2, TMPRSS2, and Furin expression in the nose and olfactory bulb in mice and humans. Rhinology. 2020; 59(1):105-109. DOI: 10.4193/Rhin20.324. View

Jiao L, Yang Y, Yu W, Zhao Y, Long H, Gao J . The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys. Signal Transduct Target Ther. 2021; 6(1):169. PMC: 8065334. DOI: 10.1038/s41392-021-00591-7. View

Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L . Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020; 71(15):889-890. PMC: 7184514. DOI: 10.1093/cid/ciaa330. View

Qiu C, Cui C, Hautefort C, Haehner A, Zhao J, Yao Q . Olfactory and Gustatory Dysfunction as an Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study. Otolaryngol Head Neck Surg. 2020; 163(4):714-721. PMC: 7298561. DOI: 10.1177/0194599820934376. View

Glezer I, Bruni-Cardoso A, Schechtman D, Malnic B . Viral infection and smell loss: The case of COVID-19. J Neurochem. 2020; 157(4):930-943. PMC: 7537178. DOI: 10.1111/jnc.15197. View

Liang F . Sustentacular Cell Enwrapment of Olfactory Receptor Neuronal Dendrites: An Update. Genes (Basel). 2020; 11(5). PMC: 7291085. DOI: 10.3390/genes11050493. View

Li Y, Bai W, Hashikawa T . The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92(6):552-555. PMC: 7228394. DOI: 10.1002/jmv.25728. View

10.

Butowt R, Bilinska K . SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection. ACS Chem Neurosci. 2020; 11(9):1200-1203. DOI: 10.1021/acschemneuro.0c00172. View

11.

Puelles V, Lutgehetmann M, Lindenmeyer M, Sperhake J, Wong M, Allweiss L . Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med. 2020; 383(6):590-592. PMC: 7240771. DOI: 10.1056/NEJMc2011400. View

12.

Klopfenstein T, Kadiane-Oussou N, Toko L, Royer P, Lepiller Q, Gendrin V . Features of anosmia in COVID-19. Med Mal Infect. 2020; 50(5):436-439. PMC: 7162775. DOI: 10.1016/j.medmal.2020.04.006. View

13.

Vaira L, Hopkins C, Sandison A, Manca A, Machouchas N, Turilli D . Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia. J Laryngol Otol. 2020; 134(12):1123-1127. PMC: 7729153. DOI: 10.1017/S0022215120002455. View

14.

Cantuti-Castelvetri L, Ojha R, Pedro L, Djannatian M, Franz J, Kuivanen S . Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020; 370(6518):856-860. PMC: 7857391. DOI: 10.1126/science.abd2985. View

15.

Ahmad I, Rathore F . Neurological manifestations and complications of COVID-19: A literature review. J Clin Neurosci. 2020; 77:8-12. PMC: 7200361. DOI: 10.1016/j.jocn.2020.05.017. View

16.

Chen R, Wang K, Yu J, Howard D, French L, Chen Z . The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains. Front Neurol. 2021; 11:573095. PMC: 7855591. DOI: 10.3389/fneur.2020.573095. View

17.

Lima M, Siokas V, Aloizou A, Liampas I, Mentis A, Tsouris Z . Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System. Curr Treat Options Neurol. 2020; 22(11):37. PMC: 7515807. DOI: 10.1007/s11940-020-00647-z. View

18.

Guadarrama-Ortiz P, Choreno-Parra J, Sanchez-Martinez C, Pacheco-Sanchez F, Rodriguez-Nava A, Garcia-Quintero G . Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations. Front Neurol. 2020; 11:1039. PMC: 7499054. DOI: 10.3389/fneur.2020.01039. View

19.

Fodoulian L, Tuberosa J, Rossier D, Boillat M, Kan C, Pauli V . SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain. iScience. 2020; 23(12):101839. PMC: 7685946. DOI: 10.1016/j.isci.2020.101839. View

20.

Vaira L, Deiana G, Fois A, Pirina P, Madeddu G, De Vito A . Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck. 2020; 42(6):1252-1258. PMC: 7267244. DOI: 10.1002/hed.26204. View